NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
China Natural Investment (HKG: 8250)
8250 Technical Analysis
2
As on 1st Nov 2017 8250 Share Price closed @ 0.08 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.09 & Strong Buy for SHORT-TERM with Stoploss of 0.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
8250 Share Price
Open | 0.07 | Change | Price | % |
High | 0.08 | 1 Day | 0.00 | 0.00 |
Low | 0.07 | 1 Week | 0.00 | 0.00 |
Close | 0.08 | 1 Month | 0.02 | 33.33 |
Volume | 5560000 | 1 Year | -0.06 | -42.86 |
52 Week High 0.15 | 52 Week Low 0.04 |
HKG HongKong Most Active Stocks
0582 | 0.21 | -4.55% |
0835 | 0.06 | 0.00% |
3988 | 3.87 | -0.51% |
8129 | 0.08 | 166.67% |
0566 | 3.91 | 0.00% |
0136 | 0.40 | -4.76% |
1880 | 6.24 | 0.00% |
1398 | 6.26 | 1.13% |
8021 | 0.03 | 50.00% |
0939 | 6.95 | -0.14% |
HKG HongKong Top Gainers Stocks
HKG HongKong Top Losers Stocks
8250 Daily Charts |
8250 Intraday Charts |
Whats New @ Bazaartrend |
8250 Free Analysis |
|
8250 Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
RESISTANCE | 0.09 |
RESISTANCE | 0.09 |
SUPPORT | 0.07 |
SUPPORT | 0.07 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
8250 Target for Month March
4th UP TARGET | 0.18 |
3rd UP TARGET | 0.15 |
2nd UP TARGET | 0.13 |
1st UP TARGET | 0.11 |
1st DOWN TARGET | 0.05 |
2nd DOWN TARGET | 0.03 |
3rd DOWN TARGET | 0.01 |
4th DOWN TARGET | -0.02 |
8250 Weekly Target
4th UP TARGET | 0.00 |
3rd UP TARGET | 0.00 |
2nd UP TARGET | 0.00 |
1st UP TARGET | 0.00 |
1st DOWN TARGET | 0.00 |
2nd DOWN TARGET | 0.00 |
3rd DOWN TARGET | 0.00 |
4th DOWN TARGET | 0.00 |
8250 Target for Year 2021
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
China Natural Investment ( HKG HongKong Symbol : 8250 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
8250 Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | Healthcare | |
Industry | Medical Laboratories & Research | |
Offical website | > echo $website ; ?> |
8250 Address
![]() |
West Tower 19th Floor Central, Hong Kong Phone: 852 2559 2210 Fax: 852 2559 2235 |
8250 Latest News
8250 Business Profile
China Natural Investment Company Limited, an investment holding company, manufactures and sells pharmaceutical products in Hong Kong. It operates through two segments, Healthcare and Pharmaceutical, and Advertising and Public Relations. The company also provides diagnostic testing and healthcare services relating to liver diseases in Hong Kong. In addition, it offers advertising and public relations services. The company was formerly known as Core Healthcare Investment Holdings Limited and changed its name to China Natural Investment Company Limited in January 2011. China Natural Investment Company Limited is headquartered in Central, Hong Kong.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service